


国际肿瘤学杂志››2014,Vol. 41››Issue (12): 896-898.doi:10.3760/cma.j.issn.1673-422X.2014.12.006
出版日期:2014-12-24发布日期:2015-02-02通讯作者:张日,Email:zhang_r_i@163.com
Online:2014-12-24Published:2015-02-02Contact:Zhang Ri, Email: zhang_r_i@163.com摘要:肿瘤干细胞是一类具有自我更新、分化和高度致瘤能力的细胞亚群,其与肿瘤的发生、发展、复发以及治疗抵抗等密切相关,而其中最重要的特性是自我更新能力。深入研究肿瘤干细胞的自我更新调控机制,对于开发以肿瘤干细胞为靶点的新型靶向治疗药物具有重要意义。
王彤, 祁小飞, 张日. 肿瘤干细胞的自我更新机制[J]. 国际肿瘤学杂志, 2014, 41(12): 896-898.
WANG Tong, QI Xiao-Fei, ZHANG Ri. Self-renewal mechanism of cancer stem cells[J]. Journal of International Oncology, 2014, 41(12): 896-898.
| [1] Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells—perspectives on current status and future directions: AACR Workshop on cancer stem cells[J]. Cancer Res, 2006, 66(19): 93399344. [2] Prezioso C, Orlando V. Polycomb proteins in mammalian cell differentiation and plasticity[J]. FEBS Lett, 2011, 585(13): 20672077. [3] Su Y, Deng B, Xi R. Polycomb group genes in stem cell selfrenewal: a doubleedged sword[J]. Epigenetics, 2011, 6(1): 1619. [4] Kaustov L, Ouyang H, Amaya M, et al. Recognition and specificity determinants of the human cbx chromodomains[J]. J Biol Chem, 2011, 286(1): 521529. [5] Kalushkova A, Frykns M, Lemaire M, et al. Polycomb target genes are silenced in multiple myeloma[J]. PLoS One, 2010, 5(7): e11483. [6] Vincent A, Van Seuningen I. On the epigenetic origin of cancer stem cells[J]. Biochim Biophys Acta, 2012, 1826(1): 8388. [7] Siddique HR, Saleem M. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences[J]. Stem Cells, 2012, 30(3): 372378. [8] Schuringa JJ, Vellenga E. Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells[J]. Curr Opin Hematol, 2010, 17(4): 294299. [9] Rizo A, Olthof S, Han L, et al. Repression of BMI1 in normal and leukemic human CD34+ cells impairs selfrenewal and induces apoptosis[J]. Blood, 2009, 114(8): 14981505. [10] Xu Z, Liu H, Lv X, et al. Knockdown of the Bmi1 oncogene inhibits cell proliferation and induces cell apoptosis and is involved in the decrease of Akt phosphorylation in the human breast carcinoma cell line MCF7[J]. Oncol Rep, 2011, 25(2): 409418. [11] Kreso A, van Galen P, Pedley NM, et al. Selfrenewal as a therapeutic target in human colorectal cancer[J]. Nat Med, 2014, 20(1): 2936. [12] Yu CC, Lo WL, Chen YW, et al. Bmi1 regulates snail expression and promotes metastasis ability in head and neck squamous cancerderived ALDH1 positive cells[J]. J Oncol, 2011. [13] Honig A, Weidler C, Husler S, et al. Overexpression of polycomb protein BMI1 in human specimens of breast, ovarian, endometrial and cervical cancer[J]. Anticancer Res, 2010, 30(5): 15591564. [14] Luo M, Shen DX, Guo XT, et al. Clinicopathological and prognostic significance of Bmi1 expression in human cervical cancer[J]. Acta Obstet Gynecol Scand, 2011, 90(7): 737745. [15] Tu Y, Gao X, Li G, et al. MicroRNA218 inhibits glioma invasion, migration, proliferation, and cancer stemlike cell selfrenewal by targeting the polycomb group gene Bmi1[J]. Cancer Res, 2013, 73(19): 60466055. [16] van Vlerken LE, Kiefer CM, Morehouse C, et al. EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporter[J]. Stem Cells Transl Med, 2013, 2(1): 4352. [17] Chatoo W, Abdouh M, Duparc RH, et al. Bmi1 distinguishes immature retinal progenitor/stem cells from the main progenitor cell population and is required for normal retinal development[J]. Stem Cells, 2010, 28(8): 14121423. [18] Yadirgi G, Leinster V, Acquati S, et al. Conditional activation of Bmi1 expression regulates selfrenewal, apoptosis, and differentiation of neural stem/progenitor cells in vitro and in vivo[J]. Stem Cells, 2011, 29(4): 700712. [19] Pritsker M, Ford NR, Jenq HT, et al. Genomewide gainoffunction genetic screen identifies functionally active genes in mouse embryonic stem cells[J]. Proc Natl Acad Sci, 2006, 103(18): 69466951. [20] Lin SL, Chang DC, Ying SY, et al. MicroRNA miR302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways[J]. Cancer Res, 2010, 70(22): 94739482. [21] Mathieu J, RuoholaBaker H. Regulation of stem cell populations by microRNAs[J]. Adv Exp Med Biol, 2013, 786: 329351. [22] Yu F, Yao H, Zhu P, et al. Let7 regulates self renewal and tumorigenicity of breast cancer cells[J]. Cell, 2007, 131(6): 11091123. [23] Guo L, Chen C, Shi M, et al. Stat3coordinated Lin28let7HMGA2 and miR200ZEB1 circuits initiate and maintain oncostatin Mdriven epithelialmesenchymal transition[J]. Oncogene, 2013, 32(45): 52775282. [24] Won HY, Lee JY, Shin DH, et al. Loss of Mel18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway[J]. FASEB J, 2012, 26(12): 50025013. [25] Harrison H, Farnie G, Howell SJ, et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor[J]. Cancer Res, 2010, 70(2): 709718. [26] Po A, Ferretti E, Miele E, et al. Hedgehog controls neural stem cells through p53independent regulation of Nanog[J]. EMBO J, 2010, 29(15): 26462658. |
| [1] | 刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325. |
| [2] | 杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337. |
| [3] | 袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343. |
| [4] | 陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349. |
| [5] | 郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353. |
| [6] | 张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358. |
| [7] | 许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363. |
| [8] | 王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369. |
| [9] | 张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375. |
| [10] | 高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381. |
| [11] | 王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384. |
| [12] | 刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273. |
| [13] | 杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279. |
| [14] | 王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285. |
| [15] | 张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291. |
| 阅读次数 | ||||||
| 全文 |
|
|||||
| 摘要 |
|
|||||